Market capitalization | $279.46m |
Enterprise Value | $283.92m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 0.64 |
P/S ratio (TTM) P/S ratio | 0.63 |
P/B ratio (TTM) P/B ratio | 0.66 |
Revenue growth (TTM) Revenue growth | 16.04% |
Revenue (TTM) Revenue | $441.03m |
As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.
16 Analysts have issued a Accolade forecast:
16 Analysts have issued a Accolade forecast:
Aug '24 |
+/-
%
|
||
Revenue | 441 441 |
16%
16%
|
|
Gross Profit | 168 168 |
34%
34%
|
|
EBITDA | -49 -49 |
48%
48%
|
EBIT (Operating Income) EBIT | -94 -94 |
33%
33%
|
Net Profit | -80 -80 |
43%
43%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Accolade, Inc. is an emerging growth company, which engages in the provision of personalized, technology-enabled solutions through a technology platform. It offers Accolade Total Benefits and Accolade Total Care. Accolade Total Benefits focuses on member benefits engagement and Accolade Total Care help guides members to healthcare providers. The company was founded by Thomas K. Spann and J. Michael Cline in 2007 and is headquartered in Seattle, WA.
Head office | United States |
CEO | Rajeev Singh |
Employees | 2,400 |
Founded | 2007 |
Website | www.accolade.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.